TE_53
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | AluSz, SVA_E |
|---|---|
| TE superfamily | Alu, SVA |
| TE order | Retroposon, SINE |
| Gene | RPL22 |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 1.23 |
| Counts of samples | TCGA_tumor:99; TCGA_normal:5; GTEx:86 |
| TSS | chr1(-):6202693 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_53.1 | RPL22 | Chimeric | Non-coding | Non-coding | chr1(-):6193034,6193054,6197652,6197756,6200489,6200750,6202631,6202694 |
| teRNA_53.2 | RPL22 | Chimeric | Non-coding | Non-coding | chr1(-):6186796,6186816,6192930,6193054,6197652,6197756,6200489,6200832,6202631,6202694 |
| teRNA_53.3 | RPL22 | Chimeric | Non-coding | Non-coding | chr1(-):6193034,6193054,6197652,6197756,6200489,6200832,6202631,6202694 |
| teRNA_53.4 | RPL22 | Chimeric | Non-coding | Non-coding | chr1(-):6193034,6193054,6197652,6197756,6200489,6200727,6202631,6202694 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
